Epstein-Barr Virus Type 2 Latently Infects T Cells, Inducing an Atypical Activation Characterized by Expression of Lymphotactic Cytokines
Open Access
- 15 February 2015
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 89 (4) , 2301-2312
Abstract
Epstein-Barr virus (EBV) is a well-established B-cell-tropic virus associated with various lymphoproliferative diseases of both B-cell and non-B-cell origin. EBV is associated with a number of T-cell lymphomas; however,in vitrostudies utilizing prototypical EBV type 1 (EBV-1) laboratory strains have generally failed to readily infect mature T cells in culture. The difficulties in performingin vitroT-cell experiments have left questions regarding the role of EBV in the pathogenesis of EBV-positive T-cell lymphoproliferative diseases largely unresolved. We report here that the EBV type 2 (EBV-2) strain displays a unique cell tropism for T cells. In remarkable contrast to EBV-1, EBV-2 readily infects primary T cellsin vitro, demonstrating a propensity for CD8+T cells. EBV-2 infection of purified T cells results in expression of latency genes and ultimately leads to T-cell activation, substantial proliferation, and profound alteration of cytokine expression. The pattern of cytokine production is strikingly skewed toward chemokines with roles in lymphocyte migration, demonstrating that EBV-2 has the ability to modulate normal T-cell processes. Collectively, these novel findings identify a previously unknown cell population potentially utilized by EBV-2 to establish latency and lay the foundation for further studies to elucidate the role of EBV in the pathogenesis of T-cell lymphoproliferative diseases.IMPORTANCEThe ability of EBV to infect T cells is made apparent by its association with a variety of T-cell lymphoproliferative disorders. However, studies to elucidate the pathogenic role of EBV in these diseases have been limited by the inability to conductin vitroT-cell infection experiments. Here, we report that EBV-2 isolates, compromised in the capacity to immortalize B cells, infect CD3+T cellsex vivoand propose a working model of EBV-2 persistence where alteration of T-cell functions resulting from EBV-2 infection enhances the establishment of latency in B cells. If indeed EBV-2 utilizes T cells to establish a persistent infection, this could provide one mechanism for the association of EBV with T-cell lymphomas. The novel finding that EBV-2 infects T cells in culture will provide a model to understand the role EBV plays in the development of T-cell lymphomas.Keywords
This publication has 54 references indexed in Scilit:
- Analysis of Epstein-Barr Virus-Regulated Host Gene Expression Changes through Primary B-Cell Outgrowth Reveals Delayed Kinetics of Latent Membrane Protein 1-Mediated NF-κB ActivationJournal of Virology, 2012
- Genomic Sequencing and Comparative Analysis of Epstein-Barr Virus Genome Isolated from Primary Nasopharyngeal Carcinoma BiopsyPLOS ONE, 2012
- C-Terminal Region of EBNA-2 Determines the Superior Transforming Ability of Type 1 Epstein-Barr Virus by Enhanced Gene Regulation of LMP-1 and CXCR7PLOS Pathogens, 2011
- Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United StatesBlood, 2011
- Detection of EBV genomes in plasmablasts/plasma cells and non-B cells in the blood of most patients with EBV lymphoproliferative disorders by using Immuno-FISHBlood, 2010
- Differential Gene Regulation by Epstein-Barr Virus Type 1 and Type 2 EBNA2Journal of Virology, 2008
- Epstein-Barr virus: a paradigm for persistent infection – for real and in virtual realityTrends in Immunology, 2008
- EBV the prototypical human tumor virus—just how bad is it?Journal of Allergy and Clinical Immunology, 2005
- Persistence of the Epstein–Barr Virus and the Origins of Associated LymphomasNew England Journal of Medicine, 2004
- IL-8-Induced T-Lymphocyte Migration: Direct as Well as Indirect MechanismsMethods, 1996